Literature DB >> 26287660

Variant Rett syndrome in a girl with a pericentric X-chromosome inversion leading to epigenetic changes and overexpression of the MECP2 gene.

José Pedro Vieira1, Fátima Lopes2, Anabela Silva-Fernandes2, Maria Vânia Sousa1, Sofia Moura2, Susana Sousa2, Bruno M Costa2, Mafalda Barbosa3, Bauke Ylstra4, Teresa Temudo5, Teresa Lourenço1, Patrícia Maciel6.   

Abstract

Rett syndrome is a neurodevelopmental disorder caused by mutations in the MECP2 gene. We investigated the genetic basis of disease in a female patient with a Rett-like clinical. Karyotype analysis revealed a pericentric inversion in the X chromosome -46,X,inv(X)(p22.1q28), with breakpoints in the cytobands where the MECP2 and CDKL5 genes are located. FISH analysis revealed that the MECP2 gene is not dislocated by the inversion. However, and in spite of a balanced pattern of X inactivation, this patient displayed hypomethylation and an overexpression of the MECP2 gene at the mRNA level in the lymphocytes (mean fold change: 2.55±0.38) in comparison to a group of control individuals; the expression of the CDKL5 gene was similar to that of controls (mean fold change: 0.98±0.10). No gains or losses were detected in the breakpoint regions encompassing known or suspected transcription regulatory elements. We propose that the de-regulation of MECP2 expression in this patient may be due to alterations in long-range genomic interactions caused by the inversion and hypothesize that this type of epigenetic de-regulation of the MECP2 may be present in other RTT-like patients.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Epigenetics; Epilepsy; Intellectual disability; Neurodevelopment

Mesh:

Substances:

Year:  2015        PMID: 26287660     DOI: 10.1016/j.ijdevneu.2015.07.010

Source DB:  PubMed          Journal:  Int J Dev Neurosci        ISSN: 0736-5748            Impact factor:   2.457


  7 in total

Review 1.  Maternal Factors that Induce Epigenetic Changes Contribute to Neurological Disorders in Offspring.

Authors:  Avijit Banik; Deepika Kandilya; Seshadri Ramya; Walter Stünkel; Yap Seng Chong; S Thameem Dheen
Journal:  Genes (Basel)       Date:  2017-05-24       Impact factor: 4.096

2.  MeCP2 Promotes Gastric Cancer Progression Through Regulating FOXF1/Wnt5a/β-Catenin and MYOD1/Caspase-3 Signaling Pathways.

Authors:  Lingyu Zhao; Yingxun Liu; Dongdong Tong; Yannan Qin; Juan Yang; Meng Xue; Ning Du; Liying Liu; Bo Guo; Ni Hou; Jia Han; Siyuan Liu; Na Liu; Xiaoge Zhao; Lumin Wang; Yanke Chen; Chen Huang
Journal:  EBioMedicine       Date:  2017-01-17       Impact factor: 8.143

3.  DNA methylation in adults and during development of the self-fertilizing mangrove rivulus, Kryptolebias marmoratus.

Authors:  Alexandre Fellous; Tiphaine Labed-Veydert; Mélodie Locrel; Anne-Sophie Voisin; Ryan L Earley; Frederic Silvestre
Journal:  Ecol Evol       Date:  2018-05-15       Impact factor: 2.912

Review 4.  Systematics for types and effects of DNA variations.

Authors:  Mauno Vihinen
Journal:  BMC Genomics       Date:  2018-12-28       Impact factor: 3.969

5.  Whole-genome analysis for effective clinical diagnosis and gene discovery in early infantile epileptic encephalopathy.

Authors:  Betsy E P Ostrander; Russell J Butterfield; Brent S Pedersen; Andrew J Farrell; Ryan M Layer; Alistair Ward; Chase Miller; Tonya DiSera; Francis M Filloux; Meghan S Candee; Tara Newcomb; Joshua L Bonkowsky; Gabor T Marth; Aaron R Quinlan
Journal:  NPJ Genom Med       Date:  2018-08-13       Impact factor: 8.617

6.  MeCP2 facilitates breast cancer growth via promoting ubiquitination-mediated P53 degradation by inhibiting RPL5/RPL11 transcription.

Authors:  DongDong Tong; Jing Zhang; XiaoFei Wang; Qian Li; Li Ying Liu; Juan Yang; Bo Guo; Lei Ni; LingYu Zhao; Chen Huang
Journal:  Oncogenesis       Date:  2020-06-01       Impact factor: 7.485

7.  A plasma SNORD33 signature predicts platinum benefit in metastatic triple-negative breast cancer patients.

Authors:  Biyun Wang; Yannan Zhao; Yi Li; Yingying Xu; Yun Chen; Qiuyu Jiang; Dingjin Yao; Li Zhang; Xichun Hu; Chaowei Fu; Si Zhang; She Chen
Journal:  Mol Cancer       Date:  2022-01-18       Impact factor: 27.401

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.